Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 93 citing articles:

1,2,3‐Triazole hybrids as anticancer agents: A review
Mohammad Mahboob Alam
Archiv der Pharmazie (2021) Vol. 355, Iss. 1
Closed Access | Times Cited: 214
Synthesis, Structural Investigations, DNA/BSA Interactions, Molecular Docking Studies, and Anticancer Activity of a New 1,4-Disubstituted 1,2,3-Triazole Derivative
Tolga Göktürk, Esin Sakallı Çetin, Tuncer Hökelek, et al.
ACS Omega (2023) Vol. 8, Iss. 35, pp. 31839-31856
Open Access | Times Cited: 25
Efficient synthesis and molecular docking analysis of quinazoline and azole hybrid derivatives as promising agents for anti-cancer and anti-tuberculosis activities
Gourav Kumar, Parveen Kumar, Akta Soni, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138289-138289
Closed Access | Times Cited: 10
New 1,2,4-triazole based eugenol derivatives as antiCOX-2 and anticancer agents
Mohammad Mahboob Alam
Journal of Umm Al-Qura University for Applied Sciences (2024) Vol. 10, Iss. 3, pp. 555-566
Open Access | Times Cited: 9
Unveiling the structural and theoretical properties of 6-(2-fluoro-3-methylpyridin-4-yl)-2-(4-methoxyphenyl)-N-phenylquinoline-4-carboxamide compound as Sonic Hedgehog protein inhibitor: Synthesis, SCXRD, HSA, DFT, Docking and ADMET studies
Veeresha Gowda Shalini, Dheeraj Kumar, Darshini Gowda, et al.
Journal of Molecular Structure (2025), pp. 141495-141495
Closed Access | Times Cited: 1
Synthesis, DFT and In Silico Anti-COVID Evaluation of Novel Tetrazole Analogues
Jyothis Devasia, Sampath Chinnam, Kavita Khatana, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 3, pp. 1941-1956
Closed Access | Times Cited: 35
Synthesis of a new sulfadimidine Schiff base and their nano complexes as potential anti-COVID-19 and anti-cancer activity
Shimaa Hosny, Mona S. Ragab, Randa F. Abd El-Baki
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Synthesis, molecular modeling investigation, molecular dynamic and ADME prediction of some novel Mannich bases derived from 1,2,4-triazole, and assessment of their anticancer activity
Sevda Manap, Hilal Medetalibeyoğlu, Ahsen Kılıç, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11916-11930
Closed Access | Times Cited: 17
Significance of Triazole in Medicinal Chemistry: Advancement in Drug Design, Reward and Biological Activity
Mohammad Ajmal, Arun Kumar Mahato, Mausin Khan, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 7
Closed Access | Times Cited: 7
Design and synthesis of chromene-1,2,3-triazole benzene sulfonamide hybrids as potent carbonic anhydrase-IX inhibitors against prostate cancer
Fawzia Faleh Albelwi, Mohamed S. Nafie, Nader R. Albujuq, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2440-2461
Closed Access | Times Cited: 6
Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation
Mohamed Reda Aouad, Meshal A. Almehmadi, Fawzia Faleh Albelwi, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105816-105816
Closed Access | Times Cited: 26
Zinc Oxide Nanoparticles as Efficient Heterogeneous Catalyst for Synthesis of Bio‐active Heterocyclic Compounds
Gourav Kumar, Vijesh Tomar, Parveen Kumar, et al.
ChemistrySelect (2023) Vol. 8, Iss. 41
Closed Access | Times Cited: 15
Synthesis, Characterizations, and Quantum Chemical Investigations on Imidazo[1,2-a]pyrimidine-Schiff Base Derivative: (E)-2-Phenyl-N-(thiophen-2-ylmethylene)imidazo[1,2-a]pyrimidin-3-amine
Mohamed Azzouzi, Omar Azougagh, Abderrahim Ait Ouchaoui, et al.
ACS Omega (2023) Vol. 9, Iss. 1, pp. 837-857
Open Access | Times Cited: 15
Novel asymmetrical azines appending 1,3,4-thiadiazole sulfonamide: synthesis, molecular structure analyses, in silico ADME, and cytotoxic effect
Samir Bondock, Tallah Albarqi, Ibrahim A. Shaaban, et al.
RSC Advances (2023) Vol. 13, Iss. 15, pp. 10353-10366
Open Access | Times Cited: 14
Structural elucidation and in-silico evaluation of 1,2,4-triazole derivative as potent Omicron variant of SARS-CoV-2 spike protein inhibitor with pharmacokinetics ADMET and drug-likeness predictions
Dheeraj Kumar, B.S. Chethan, Veeresha Gowda Shalini, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136976-136976
Closed Access | Times Cited: 14
Synthesis and biological evaluation of ciprofloxacin – 1,2,3-triazole hybrids as antitumor, antibacterial, and antioxidant agents
Samir Al-Taweel, Yousef M. Al-saraireh, Salah A. Al‐Trawneh, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22592-e22592
Open Access | Times Cited: 14
An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential
Anirudh Pratap Singh Raman, M. Aslam, Amardeep Awasthi, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 5
Synthetic and Medicinal Perspective of 1,2,4‐Triazole as Anticancer Agents
Bhagyashri Rathod, Kapil Kumar
Chemistry & Biodiversity (2022) Vol. 19, Iss. 11
Closed Access | Times Cited: 22
Synthesis of novel indole-oxindole clubbed 1,2,3-triazole hybrids: antimicrobial evaluation and molecular docking study
Jaydeep A. Mokariya, Reena C. Patel, Dhanji P. Rajani, et al.
Research on Chemical Intermediates (2023) Vol. 49, Iss. 7, pp. 2933-2953
Closed Access | Times Cited: 12
Synthesis, biological profile and computational insights of new derivatives of benzo [B][1,4] diazepines as prospective anticancer agents for inhibiting the CDK-2 protein
Pervaiz Dar, Basharat Bhat, Mushtaq Ahmad Mir, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Open Access | Times Cited: 4
N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity
Aeshah A. Awaji, Waheed Ali Zaki El Zaloa, Mohamed A. Seleem, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107228-107228
Closed Access | Times Cited: 4
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108131-108131
Closed Access
Pharmacological Significance of 1,2,3-Triazoles
Mubarak H. Shaikh, Amol A. Nagargoje, Dattatraya N. Pansare, et al.
Advances in chemical and materials engineering book series (2025), pp. 155-202
Closed Access
A Multifaceted Computational Approach to Identify PAD4 Inhibitors for the Treatment of Rheumatoid Arthritis (RA)
Mansour S. Alturki, Mohamed S. Gomaa, Nada Tawfeeq, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 156-156
Open Access
Synthesis of new sulfa drugs containing FDA-approved sulfa pyridine: Evaluation of cholinesterase inhibition, antimicrobial, antibiofilm, anticancer, and antioxidant activities, along with theoretical calculation and molecular docking study
N.Z. Ibrahimova, Servet Çete, Deniz Akın Anakök, et al.
Journal of Molecular Structure (2025) Vol. 1335, pp. 142013-142013
Closed Access
Page 1 - Next Page

Scroll to top